FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...

Verizon's strong $50B EBITDA and $4B quarterly FCF highlight resilience amid challenges. Click here to read why VZ stock is a ...

CVR Partners also announced that on April 28, 2025, the Board of Directors of the Partnership's general partner (the "Board”) ...

IBM Corporation (IBM) reported Good free cash flow results last week for Q1, including high FCF margins. Given its apparent cheapness, is it time to buy IBM stock now? One way to play this is to short ...